Copyright
©The Author(s) 2022.
World J Diabetes. Jul 15, 2022; 13(7): 532-542
Published online Jul 15, 2022. doi: 10.4239/wjd.v13.i7.532
Published online Jul 15, 2022. doi: 10.4239/wjd.v13.i7.532
Table 6 Comparison of clinical efficiency between the two groups, n (%)
| Groups | Markedly efficiency | Efficient | Invalid |
| Compaq group (n = 48) | 34 (70.83) | 13 (27.08) | 1 (2.08) |
| Ranibizumab group (n = 48) | 25 (52.08) | 19 (39.58) | 4 (8.33) |
| Z value | -1.993 | ||
| P value | 0.046 | ||
- Citation: Li YF, Ren Q, Sun CH, Li L, Lian HD, Sun RX, Su X, Yu H. Efficacy and mechanism of anti-vascular endothelial growth factor drugs for diabetic macular edema patients. World J Diabetes 2022; 13(7): 532-542
- URL: https://www.wjgnet.com/1948-9358/full/v13/i7/532.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i7.532